Evolus, Inc.
Industry: Life Sciences ・ $EOLS on Nasdaq
Insider Sale
+$204,169
-2.33%
Shares
Shares Volume: 16,051 Shares
Average Share Price: $12.72
INSIDER
MOATAZEDI DAVID
See Remarks (Director)
reported on May 14 2024
traded on May 10 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 673,563 |
| PURCHASES/SALES 1Y | 0 / 6 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $451,067.44 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 3 |
| PURCHASES/SALES 1Y | 1 / 16 |
| P/S VALUE RATIO | 0.368 |
| AVERAGE SALE VALUE | $220,302.12 |
| COMPANY PREVIOUS TRADES |